Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
Boston University Medical School
2485
mi
from 98109
Boston, MA
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Boston University Medical School
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
Tufts Medical Center
2485
mi
from 98109
Boston, MA
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Tufts Medical Center
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
University of Michigan-Scleroderma Program
1903
mi
from 98109
Ann Arbor, MI
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
University of Michigan-Scleroderma Program
1903
mi
from 98109
Ann Arbor, MI
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
Univ of Minnesota
1393
mi
from 98109
Minneapolis, MN
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Univ of Minnesota
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
University Medicine and Dentistry of New Jersey
2388
mi
from 98109
New Brunswick, NJ
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
University Medicine and Dentistry of New Jersey
2388
mi
from 98109
New Brunswick, NJ
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
Center for Rheumatology
2351
mi
from 98109
Albany, NY
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Center for Rheumatology
2351
mi
from 98109
Albany, NY
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
North Shore Long Island Jewish Medical Center
2416
mi
from 98109
New Hyde Park, NY
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
North Shore Long Island Jewish Medical Center
2416
mi
from 98109
New Hyde Park, NY
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
Cornell University
2402
mi
from 98109
New York, NY
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Cornell University
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
Hospital for Special Surgery
2402
mi
from 98109
New York, NY
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Hospital for Special Surgery
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
Univ of Pennsylvania
2371
mi
from 98109
Philadelphia, PA
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Univ of Pennsylvania
2371
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
University of Pittsburgh
2134
mi
from 98109
Pittsburgh, PA
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
University of Pittsburgh
2134
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
University of Utah
703
mi
from 98109
Salt Lake City, UT
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
University of Utah
703
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
Medical College of Wisconsin
1687
mi
from 98109
Milwaukee, WI
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Medical College of Wisconsin
1687
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
Northwestern University
1733
mi
from 98109
Chicago, IL
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Northwestern University
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
University of Massachussetts Memorial Medical Center
2454
mi
from 98109
Worcester, MA
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
University of Massachussetts Memorial Medical Center
2454
mi
from 98109
Worcester, MA
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
Hennepin County Medical Center
1393
mi
from 98109
Minneapolis, MN
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Hennepin County Medical Center
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
University of Texas Health Science Center
1892
mi
from 98109
Houston, TX
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
University of Texas Health Science Center
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
Arizona Research Center
1104
mi
from 98109
Phoenix, AZ
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Arizona Research Center
1104
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
Bakersfield Dermatology and Skin Cancer Medical Group
864
mi
from 98109
Bakersfield, CA
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Bakersfield Dermatology and Skin Cancer Medical Group
864
mi
from 98109
Bakersfield, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
Dermatology Research Associates
966
mi
from 98109
Los Angeles, CA
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Dermatology Research Associates
966
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
Renstar Medical Research
2483
mi
from 98109
Ocala, FL
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Renstar Medical Research
2483
mi
from 98109
Ocala, FL
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
Advanced Medical Research, Inc.
2174
mi
from 98109
Atlanta, GA
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Advanced Medical Research, Inc.
2174
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
The Emory Clinic
2180
mi
from 98109
Atlanta, GA
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
The Emory Clinic
2180
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
Northwestern University, Northwestern Medical Faculty Foundation
1732
mi
from 98109
Chicago, IL
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Northwestern University, Northwestern Medical Faculty Foundation
1732
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
Northwestern Medicine Lake Forest Hospital
1712
mi
from 98109
Lake Forest, IL
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Northwestern Medicine Lake Forest Hospital
1712
mi
from 98109
Lake Forest, IL
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
Dermatology Specialists PSC
1939
mi
from 98109
Louisville, KY
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Dermatology Specialists PSC
1939
mi
from 98109
Louisville, KY
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
Dartmouth Hitchcock Medical Center
2392
mi
from 98109
Lebanon, NH
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Dartmouth Hitchcock Medical Center
2392
mi
from 98109
Lebanon, NH
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
Mount Sinai Hospital
2401
mi
from 98109
New York, NY
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Mount Sinai Hospital
2401
mi
from 98109
New York, NY
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
NYU Department of Dermatology
2401
mi
from 98109
New York, NY
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
NYU Department of Dermatology
2401
mi
from 98109
New York, NY
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
PMG Research of Winston-Salem
2275
mi
from 98109
Winston-Salem, NC
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
PMG Research of Winston-Salem
2275
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
Oregon Health and Science University
147
mi
from 98109
Portland, OR
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Oregon Health and Science University
147
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
Virginia Clinical Research, Inc.
2429
mi
from 98109
Norfolk, VA
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Virginia Clinical Research, Inc.
2429
mi
from 98109
Norfolk, VA
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
Chih-Ho Hong Medical, Inc.
103
mi
from 98109
Surrey,
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Chih-Ho Hong Medical, Inc.
103
mi
from 98109
Surrey,
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
NVISION Camarillo
942
mi
from 98109
Camarillo, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Camarillo
942
mi
from 98109
Camarillo, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
NVISION Sacramento
619
mi
from 98109
Citrus Heights, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Sacramento
619
mi
from 98109
Citrus Heights, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
NVISION Fullerton
977
mi
from 98109
Fullerton, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Fullerton
977
mi
from 98109
Fullerton, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
NVISION Laguna Hills
999
mi
from 98109
Laguna Hills, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Laguna Hills
999
mi
from 98109
Laguna Hills, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
NVISION Newport Beach
997
mi
from 98109
Newport Beach, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Newport Beach
997
mi
from 98109
Newport Beach, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
NVISION Ontario
968
mi
from 98109
Ontario, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Ontario
968
mi
from 98109
Ontario, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
NVISION La Jolla
1065
mi
from 98109
San Diego, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION La Jolla
1065
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
Berg Feinfield Vision Center
953
mi
from 98109
Sherman Oaks, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
Berg Feinfield Vision Center
953
mi
from 98109
Sherman Oaks, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
NVISION Torrance
975
mi
from 98109
Torrance, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Torrance
975
mi
from 98109
Torrance, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
NVISION Las Vegas
873
mi
from 98109
Las Vegas, NV
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Las Vegas
873
mi
from 98109
Las Vegas, NV
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
Teplick Custom Vision
149
mi
from 98109
Beaverton, OR
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
Teplick Custom Vision
149
mi
from 98109
Beaverton, OR
Click here to add this to my saved trials
Pediatric Atopic Dermatitis (AD) Internet Survey
Using an Internet Survey to Improve Adherence in Pediatric Atopic Dermatitis
Status: Enrolling
Updated:  5/5/2016
Wake Forest University Health Sciences, Dermatology
2279
mi
from 98109
Winston-Salem, NC
Pediatric Atopic Dermatitis (AD) Internet Survey
Using an Internet Survey to Improve Adherence in Pediatric Atopic Dermatitis
Status: Enrolling
Updated: 5/5/2016
Wake Forest University Health Sciences, Dermatology
2279
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
Treatment of Actinic Keratoses (AK) on the Face
An Investigator-Initiated Study to Assess the Efficacy and Degree of Irritation of Ingenol Mebutate 0.015% Gel and Dermasil Lotion Versus Ingenol Mebuate 0.015% Alone in the Treatment of Actinic Keratoses (AK) on the Face.
Status: Enrolling
Updated:  5/12/2016
Icahn School of Medicine at Mount Sinai
mi
from 98109
New York, NY
Treatment of Actinic Keratoses (AK) on the Face
An Investigator-Initiated Study to Assess the Efficacy and Degree of Irritation of Ingenol Mebutate 0.015% Gel and Dermasil Lotion Versus Ingenol Mebuate 0.015% Alone in the Treatment of Actinic Keratoses (AK) on the Face.
Status: Enrolling
Updated: 5/12/2016
Icahn School of Medicine at Mount Sinai
mi
from 98109
New York, NY
Click here to add this to my saved trials
Actinic Keratosis Study
The Role of Calcipotriol in Treatment of Pre-cancerous Skin Lesions
Status: Enrolling
Updated:  5/18/2016
Washington University School of Medicine
1718
mi
from 98109
Saint Louis, MO
Actinic Keratosis Study
The Role of Calcipotriol in Treatment of Pre-cancerous Skin Lesions
Status: Enrolling
Updated: 5/18/2016
Washington University School of Medicine
1718
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients
Status: Enrolling
Updated:  5/19/2016
Clinical Research Facility
1020
mi
from 98109
Denver, CO
Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients
Status: Enrolling
Updated: 5/19/2016
Clinical Research Facility
1020
mi
from 98109
Denver, CO
Click here to add this to my saved trials
Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients
Status: Enrolling
Updated:  5/19/2016
Clinical Research Facility
2389
mi
from 98109
Berlin, NJ
Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients
Status: Enrolling
Updated: 5/19/2016
Clinical Research Facility
2389
mi
from 98109
Berlin, NJ
Click here to add this to my saved trials